行情

MYOS

MYOS

MYOS RENS
NASDAQ

实时行情|Nasdaq Last Sale

1.500
-0.040
0.00%
已收盘, 16:00 01/22 EST
开盘
1.500
昨收
1.500
最高
1.500
最低
1.370
成交量
3.38万
成交额
--
52周最高
2.020
52周最低
1.150
市值
1,376.54万
市盈率(TTM)
-4.1152
分时
5日
1月
3月
1年
5年

EPS

MYOS 新闻

  • 沪指重挫2.75% 国际油价跌至七周低点
  • 新浪财经.15分钟前
  • 就业数据推高澳元 疫情恐慌提振日元
  • 新浪财经.2小时前
  • 日本2019年贸易逆差1.64万亿日元
  • 新华社.3小时前
  • 绿光资本创始人:黄金是我们的十大持仓之一
  • 新浪财经综合.3小时前

更多

所属板块

食品加工
-0.32%
食品和烟类
-0.15%

热门股票

名称
价格
涨跌幅

MYOS 简况

MYOS RENS Technology Inc. (MYOS), formerly MYOS Corporation, is an early-stage bionutrition and biotherapeutics company. The Company is focused on the discovery, development and commercialization of products that improve muscle health and function essential for the management of sarcopenia, cachexia and degenerative muscle diseases, and as an adjunct to the treatment of obesity. The Company is focused on the discovery, development, and commercialization of nutritional supplements, functional foods, therapeutic products, and other technologies for maintaining the health and performance of muscle tissue. MYOS is evaluating the modulation of myostatin. Its research is focused on developing strategies and therapeutic interventions to address muscle related conditions, including sarcopenia, cachexia, and inherited and acquired muscle diseases. The Company, through its subsidiary, holds the intellectual property pertaining to Fortetropin, which is a dietary supplement.
展开

Webull提供MYOS RENS Technology Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。